Picture Emily Barker. But in an extraordinary broadside, Mr Olds said repeated instances of poor governance and efforts to undermine her colleagues during her tenure had hurt the council’s standing.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...